Skip to main content
letter
. 2023 Feb 27;12(1):e2179357. doi: 10.1080/22221751.2023.2179357

Figure 1.

Figure 1.

Humoral immune responses after boosting with BBIBP-CorV, ZF2001 or Delta-Omicron BA.1 RBD-dimer in mice. Groups of female BALB/c mice (n = 10) were immunized with two doses of 1·3 U BBIBP-CorV and boosted with homologous 1·3-U BBIBP-CorV, or 5-μg ZF2001, or 5-μg Delta-Omicron BA.1 RBD-dimer (aluminum hydroxide adjuvant) (see schedule shown in Figure S2). Both the BBIBP-CorV and ZF2001 were 1/5 of their dosages used in human. Serum samples were collected according to schedule shown in Figure S2. (A) Endpoint titers of antigen-binding IgG after the 3rd jab (day 56). (B-I) Sera 50% neutralization titers of pseudotyped viruses displaying spike proteins of prototype (B), Alpha (C), Beta (D), Delta (E), Omicron BA.1 (F), Omicron BA.2 (G), Omicron BA.2.12.1 (H) or Omicron BA.4/5 (I). (J) Radar plot demonstrating the neutralization profile of sera boosted by BBIBP-CorV, ZF2001 or Delta-Omicron BA.1 RBD-dimer against eight SARS-CoV-2 pseudotyped viruses.